Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

WORKIVA INC (WK)

  • Business News
  • May 05, 2026, 20:05 UTC
  • 5
  • 1 comments

Workiva Announces First Quarter 2026 Financial Results

Market reaction Comment Full text

ANDERSONS, INC. (ANDE)

  • Business News
  • May 05, 2026, 20:05 UTC
  • 3
  • 1 comments

The Andersons, Inc. Reports First Quarter Results

Market reaction Comment Full text

NATIONAL STORAGE AFFILIATES TRUST (NSA)

  • Business News
  • May 05, 2026, 20:05 UTC
  • 5
  • 1 comments

National Storage Affiliates Trust Reports First Quarter 2026 Results

Market reaction Comment Full text

ONKURE THERAPEUTICS, INC. (OKUR)

  • Business News
  • May 05, 2026, 20:05 UTC
  • 4
  • 1 comments

OnKure Therapeutics Reports First Quarter 2026 Financial Results

Market reaction Comment Full text

STANDARD BIOTOOLS INC. (LAB)

  • Business News
  • May 05, 2026, 20:05 UTC
  • 5
  • 1 comments

Standard BioTools Reports First Quarter 2026 Financial Results

Market reaction Comment Full text

SURO CAPITAL CORP. (SSSS)

  • Business News
  • May 05, 2026, 20:05 UTC
  • 2
  • 1 comments

SuRo Capital Corp. Reports First Quarter 2026 Financial Results

Market reaction Comment Full text

ASTERA LABS, INC. (ALAB)

  • Business News
  • May 05, 2026, 20:05 UTC
  • 4
  • 1 comments

Astera Labs Extends Leadership in Open, AI Scale-Up Networking with New 320 Lane Scorpio X-Series Smart Fabric Switch

Market reaction Comment Full text

PITNEY BOWES INC /DE/ (PBI)

  • Business News
  • May 05, 2026, 20:05 UTC
  • 3
  • 1 comments

Pitney Bowes Announces Financial Results for First Quarter 2026 and Issues CEO Letter

Market reaction Comment Full text

TERADATA CORP /DE/ (TDC)

  • Business News
  • May 05, 2026, 20:05 UTC
  • 5
  • 1 comments

Teradata Reports First Quarter 2026 Financial Results

Market reaction Comment Full text

VERRICA PHARMACEUTICALS INC. (VRCA)

  • Business News
  • May 05, 2026, 20:05 UTC
  • 5
  • 1 comments

Verrica Pharmaceuticals Announces Upcoming Presentation of Phase 2 Data Highlighting the Potential Abscopal Effects of VP-315 in the Treatment of Basal Cell Carcinoma at the 2026 Society for Investigative Dermatology (SID) Annual Meeting

Market reaction Comment Full text
  • Previous
  • 444
  • 445
  • 446
  • 447
  • 448
  • Next

Search

News categories

  • Technical Exchange News(12425)
  • Event(6229)
  • SEC News(277414)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(159897)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin